119 related articles for article (PubMed ID: 25690591)
1. Nevus anemicus: a distinctive cutaneous finding in neurofibromatosis type 1.
Hernández-Martín A; García-Martínez FJ; Duat A; López-Martín I; Noguera-Morel L; Torrelo A
Pediatr Dermatol; 2015; 32(3):342-7. PubMed ID: 25690591
[TBL] [Abstract][Full Text] [Related]
2. Nevus anemicus in neurofibromatosis type 1: a potential new diagnostic criterion.
Marque M; Roubertie A; Jaussent A; Carneiro M; Meunier L; Guillot B; Pinson L; Pinson S; Bessis D
J Am Acad Dermatol; 2013 Nov; 69(5):768-775. PubMed ID: 23972508
[TBL] [Abstract][Full Text] [Related]
3. Juvenile xanthogranuloma and nevus anemicus in the diagnosis of neurofibromatosis type 1.
Ferrari F; Masurel A; Olivier-Faivre L; Vabres P
JAMA Dermatol; 2014 Jan; 150(1):42-6. PubMed ID: 24258576
[TBL] [Abstract][Full Text] [Related]
4. Anemic nevus in neurofibromatosis type 1.
Tadini G; Brena M; Pezzani L; Gelmetti C; Santagada F; Boldrini MP
Dermatology; 2013; 226(2):115-8. PubMed ID: 23713063
[TBL] [Abstract][Full Text] [Related]
5. Nevus Anemicus As an Additional Diagnostic Marker of Neurofibromatosis Type 1 in Childhood.
Vaassen P; Rosenbaum T
Neuropediatrics; 2016 Jun; 47(3):190-3. PubMed ID: 27019377
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous and Systemic Findings in Mosaic Neurofibromatosis Type 1.
Vázquez-Osorio I; Duat-Rodríguez A; García-Martínez FJ; Torrelo A; Noguera-Morel L; Hernández-Martín A
Pediatr Dermatol; 2017 May; 34(3):271-276. PubMed ID: 28318056
[TBL] [Abstract][Full Text] [Related]
7. Nevus anemicus associated with neurofibromatosis type 1 in a neonate: a case report.
Cerini C; Pogliani L; Mameli C; Zuccotti GV
G Ital Dermatol Venereol; 2015 Dec; 150(6):745-7. PubMed ID: 26513044
[TBL] [Abstract][Full Text] [Related]
8. [Segmental neurofibromatosis in children. Presentation of 43 patients].
Pascual-Castroviejo I; Pascual-Pascual SI; Velázquez-Fragua R; Viaño J; López-Gutiérrez JC
Rev Neurol; 2008 Oct 16-31; 47(8):399-403. PubMed ID: 18937200
[TBL] [Abstract][Full Text] [Related]
9. Neurofibromatosis Type 1: Diagnostic Timelines in Children.
García-Martínez FJ; Hernández-Martín A
Actas Dermosifiliogr; 2023 Mar; 114(3):187-193. PubMed ID: 36370836
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous Manifestations not Considered Diagnostic Criteria for Neurofibromatosis Type 1. A Case-Control Study.
García-Martínez FJ; Duat-Rodríguez A; Andrés Esteban E; Torrelo A; Noguera Morel L; Hernández-Martín A
Actas Dermosifiliogr; 2022; 113(10):T923-T929. PubMed ID: 36162491
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous Manifestations not Considered Diagnostic Criteria for Neurofibromatosis Type 1. A Case-Control Study.
García-Martínez FJ; Duat-Rodríguez A; Andrés Esteban E; Torrelo A; Noguera Morel L; Hernández-Martín A
Actas Dermosifiliogr; 2022; 113(10):923-929. PubMed ID: 35636506
[TBL] [Abstract][Full Text] [Related]
12. Predicting neurofibromatosis type 1 risk among children with isolated café-au-lait macules.
Ben-Shachar S; Dubov T; Toledano-Alhadef H; Mashiah J; Sprecher E; Constantini S; Leshno M; Messiaen LM
J Am Acad Dermatol; 2017 Jun; 76(6):1077-1083.e3. PubMed ID: 28318682
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of café au lait macules at initial consultation in the diagnosis of neurofibromatosis type 1.
Nunley KS; Gao F; Albers AC; Bayliss SJ; Gutmann DH
Arch Dermatol; 2009 Aug; 145(8):883-7. PubMed ID: 19687418
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous manifestations in neurofibromatosis type 1.
Miraglia E; Moliterni E; Iacovino C; Roberti V; Laghi A; Moramarco A; Giustini S
Clin Ter; 2020; 171(5):e371-e377. PubMed ID: 32901776
[TBL] [Abstract][Full Text] [Related]
15. Ophthalmological manifestations in segmental neurofibromatosis type 1.
Ruggieri M; Pavone P; Polizzi A; Di Pietro M; Scuderi A; Gabriele A; Spalice A; Iannetti P
Br J Ophthalmol; 2004 Nov; 88(11):1429-33. PubMed ID: 15489488
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic outcome in children with multiple café au lait spots.
Korf BR
Pediatrics; 1992 Dec; 90(6):924-7. PubMed ID: 1344978
[TBL] [Abstract][Full Text] [Related]
17. Café-au-lait spots in neurofibromatosis type 1 and in healthy control individuals: hyperpigmentation of a different kind?
De Schepper S; Boucneau J; Vander Haeghen Y; Messiaen L; Naeyaert JM; Lambert J
Arch Dermatol Res; 2006 Apr; 297(10):439-49. PubMed ID: 16479403
[TBL] [Abstract][Full Text] [Related]
18. Relationship between café-au-lait spots as the only symptom and peripheral neurofibromatosis (NF1): a follow-up study.
Fois A; Calistri L; Balestri P; Vivarelli R; Bartalini G; Mancini L; Berardi A; Vanni M
Eur J Pediatr; 1993 Jun; 152(6):500-4. PubMed ID: 8335018
[TBL] [Abstract][Full Text] [Related]
19. Eye disorders in neurofibromatosis (NF1).
Kordić R; Sabol Z; Cerovski B; Katusić D; Jukić T
Coll Antropol; 2005; 29 Suppl 1():29-31. PubMed ID: 16193672
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
